Literature DB >> 36109412

Overcoming Treatment Disparities for Early-Stage Hepatocellular Carcinoma in the Veteran Population: Is the MISSION Act the Solution?

Robin Schmitz1, Michael E Lidsky2.   

Abstract

Entities:  

Mesh：

Year:  2022        PMID： 36109412     DOI： 10.1245/s10434-022-12531-y

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN： 1068-9265            Impact factor:   4.339


× No keyword cloud information.
  6 in total

Review 1.  Systemic therapy for hepatocellular carcinoma: the issue of treatment stage migration and registration of progression using the BCLC-refined RECIST.

Authors:  Maria Reig; Anna Darnell; Alejandro Forner; Jordi Rimola; Carmen Ayuso; Jordi Bruix
Journal:  Semin Liver Dis       Date:  2014-11-04       Impact factor: 6.115

2.  Disparities in care for patients with curable hepatocellular carcinoma.

Authors:  Richard S Hoehn; Dennis J Hanseman; Peter L Jernigan; Koffi Wima; Audrey E Ertel; Daniel E Abbott; Shimul A Shah
Journal:  HPB (Oxford)       Date:  2015-09       Impact factor: 3.647

Review 3.  Hepatocellular carcinoma.

Authors:  Alejandro Forner; María Reig; Jordi Bruix
Journal:  Lancet       Date:  2018-01-05       Impact factor: 79.321

4.  Underutilization of therapy for hepatocellular carcinoma in the medicare population.

Authors:  Shimul A Shah; Jillian K Smith; Youfu Li; Sing Chau Ng; James E Carroll; Jennifer F Tseng
Journal:  Cancer       Date:  2010-10-13       Impact factor: 6.860

5.  ASO Visual Abstract: Variation of Hepatocellular Carcinoma Treatment Patterns and Survival Across Geographic Regions in a Veteran Population.

Authors:  Michelle R Ju; John D Karalis; Matthieu Chansard; M Mathew Augustine; Eric Mortensen; Sam C Wang; Matthew R Porembka; Herbert J Zeh; Adam C Yopp; Patricio M Polanco
Journal:  Ann Surg Oncol       Date:  2022-10-02       Impact factor: 4.339

Review 6.  BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update.

Authors:  Maria Reig; Alejandro Forner; Jordi Rimola; Joana Ferrer-Fàbrega; Marta Burrel; Ángeles Garcia-Criado; Robin K Kelley; Peter R Galle; Vincenzo Mazzaferro; Riad Salem; Bruno Sangro; Amit G Singal; Arndt Vogel; Josep Fuster; Carmen Ayuso; Jordi Bruix
Journal:  J Hepatol       Date:  2021-11-19       Impact factor: 30.083
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.